New patent for Merck Sharp drug JANUVIA

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for JANUVIA
Annual Drug Patent Expirations for JANUVIA

Januvia is a drug marketed by Merck Sharp Dohme and is included in one NDA. It is available from three suppliers. There are three patents protecting this drug and one Paragraph IV challenge.

JANUVIA drug price trends.

Drug patent litigation for JANUVIA.

This drug has one hundred and seventeen patent family members in forty-six countries.

The generic ingredient in JANUVIA is sitagliptin phosphate. Three suppliers are listed for this compound. Additional details are available on the sitagliptin phosphate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top